Biotechnology

Science and wearable tech go hand in hand to provide athletes with precise, personalized information to improve their performance.

Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.

As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.

Drugs created with covalent inhibitors are becoming more popular than other types, owing to their unique mechanism of action.

Thanks to mRNA vaccines, which have revolutionized the fight against COVID-19, we can treat cancer by harnessing the power of the immune system.

Discover how advances in 3D printing materials and approaches have reshaped tissues and organ sourcing, drug delivery methods, and wound care.

Experts from Mayo Clinic, Direct Biologics, and Aruna Bio discuss how 3D bioprinting is reshaping disease treatment.

Investment in RNA has grown beyond vaccines. Cancer, infectious diseases, and even liver diseases have all been identified for RNA medicines.

Exosomes are reshaping the future of drug delivery, therapeutics, and diagnostics. Learn about exosomes and the challenges with the technology.

3D printing has major biomedical applications. See the new technologies that are reshaping personalized healthcare.

Exosomes have enormous potential in drug delivery, diagnostics, and more. Mayo Clinic, Direct Biologics, and Aruna Bio discuss the full landscape.

RNA medicine has spawned many new technologies and approaches. Examine market trends and where investors are funneling their money.

The expansion of exosome research has led to significant clinical advancements, and new approaches to drug delivery and diagnostics.

From prosthetic ears to artificial organs, learn about the latest trends and innovations in 3D printing in biomedicine.

We are in the middle of a 3D printing revolution, and its applications reach into biomedicine. See how it can reshape this field.

The possibilities of 3D printing in biomedicine are nearly limitless, as evidenced by this journal publication.

A historical overview of the discovery of exosomes, key milestones in their rise, and why they will revolutionize the diagnostic and drug delivery fields in the future.

Exosomes are nature’s lipid nanoparticles and their unique physical properties will unlock new applications in drug development, delivery and diagnostic applications in the future

Exosomes – nature's lipid nanoparticle, a rising star in drug delivery and diagnostics

mRNA vaccines have many potential advantages over conventional vaccines in mitigating the spread and eventually ending the COVID-19 pandemic. Learn more about mRNA vaccines and how CAS is committed to supporting the fight against COVID-19.

Molecular glues have been used to uncover new therapeutic agents. Because of their targeted protein degradation that holds them together, these glues have exciting potential in uncovering new drugs to fight cancer, immune diseases, and more.

We are in the midst of a therapeutic revolution, according to the authors of a recent review article in Frontiers in Bioengineering and Biotechnology.

It turns out that these intrinsically disordered proteins may be the key to better overcoming diseases in neurodegeneration, diabetes, cardiovascular disease, amyloidosis, genetic diseases, and cancer.

Learn about bioorthogonal chemistry and its applications, how it helped move the field of glycobiology forward, and what opportunities lie ahead.

With recent mRNA booster recommendations, many ask if they should get a COVID-19 booster and what the science shows? This blog explains the science of boosters, reviews current recommendations, and examines recent research.

Learn more about the applications of lipid nanoparticles in cancer therapy, their therapeutic benefits, and their future within nanomedicine.

In this article from The Patent Lawyer Magazine, Anne Marie Clark, Senior Search Analyst for CAS, discusses how to avoid patent pitfalls as the market for RNAi-derived therapeutics grows.